Risk Factors for Glottic Laryngeal Cancer in Non-Smokers and Non-Drinkers
In non-smoking, non-drinking patients with glottic laryngeal cancer, the primary risk factors to investigate include occupational exposures (particularly silica and polycyclic aromatic hydrocarbons), laryngopharyngeal reflux disease, genetic polymorphisms in carcinogen-metabolizing enzymes, and rare inherited cancer syndromes.
Key Risk Factors in This Population
Occupational and Environmental Exposures
The most robust evidence points to workplace carcinogens as significant contributors. Occupational exposure to silica (OR 1.7) and polycyclic aromatic hydrocarbons/PAH (OR 1.5) show statistically significant associations with laryngeal cancer in non-smoking, non-drinking men 1. Other implicated exposures include diesel exhaust, gasoline exhaust, and cotton dust 1. These occupational factors appear particularly relevant given that glottic cancer in nonsmokers represents a substantial proportion—approximately 26% of all glottic cases 2.
Gastroesophageal and Laryngopharyngeal Reflux
Chronic acid and bile reflux make a "small but significant contribution" to laryngeal cancer development 3. Case reports document glottic carcinoma in non-smoking females where laryngopharyngeal reflux was the only identifiable risk factor 4. The mechanism likely involves chronic mucosal irritation and inflammation, though the exact pathophysiology remains incompletely understood 3.
Genetic and Metabolic Factors
Inherited polymorphisms in carcinogen-metabolizing enzymes—specifically glutathione S-transferase (GSTM1, GSTT1) and human microsomal epoxide hydrolase (EPHX1)—are associated with increased head and neck squamous cell carcinoma risk 5. These genetic variations may explain why some individuals develop cancer without traditional exposures.
Rare inherited syndromes warrant consideration in specific clinical contexts: Fanconi anemia, ataxia telangiectasia, Bloom's syndrome, Li-Fraumeni syndrome, and dyskeratosis congenita 5. Genetic counseling should be pursued when patients present with cytopenias, young age at diagnosis, or family history of multiple cancers—particularly when traditional risk factors are absent 5.
HPV Infection
While HPV is a major driver of oropharyngeal cancer (30-35% of cases), HPV-positive squamous cell carcinoma outside the oropharynx is rare, occurring in less than 6% of cases 5, 6. This makes HPV an unlikely contributor to glottic cancer in non-smokers.
Additional Considerations
Other weaker risk factors include 5, 3:
- Chronic infection and long-term immunosuppression
- Poor oral hygiene and nutrition
- Prior radiation exposure
- Dietary factors (low vegetable and fruit intake may increase risk)
Clinical Implications and Patterns
Demographics and Presentation
Non-smoking patients with glottic cancer demonstrate distinct patterns 2, 7:
- All non-smoking laryngeal cancer patients in recent cohorts had glottic (not supraglottic) disease
- Female representation is significantly higher among non-smokers (25% vs 12% in smokers, p=0.008)
- Non-smoking females show a bimodal age distribution, with 74% diagnosed either under age 40 or over age 75
- Mean age at diagnosis is similar to smokers (approximately 60-67 years)
Prognosis
Five-year survival for non-smoking laryngeal cancer patients is 85%, with no significant difference compared to smokers 7. Most tumors are detected early (69% present as T1 disease), likely due to early voice changes prompting medical evaluation 7.
Common Pitfalls
Assuming absence of traditional risk factors means low suspicion: The rising proportion of non-smoking laryngeal cancer cases (22.7% in recent series, up from historical 3.8%) suggests evolving etiologies 2, 7.
Overlooking occupational history: Detailed work exposure assessment is critical but often inadequately performed in clinical practice.
Dismissing reflux as trivial: While the contribution is modest, laryngopharyngeal reflux represents a modifiable risk factor that should be systematically evaluated and treated.
Missing genetic syndromes in young patients: When patients present at age extremes without traditional exposures, inherited cancer predisposition syndromes must be considered.